https://newsroom.bankofamerica.com/content/newsroom/home/prime-rate-information.html
Codexis, Merck Amend And Extend Supply Agreement For Enzyme Used In Manufacture Of Sitagliptin
Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, announced the amendment and extension of its agreement with Merck, known as MSD outside the United States and
